These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1933372)
1. Dextromethorphan protects against the neurotoxic effects of p-chloroamphetamine in rats. Finnegan KT; Kerr JT; Langston JW Brain Res; 1991 Aug; 558(1):109-11. PubMed ID: 1933372 [TBL] [Abstract][Full Text] [Related]
2. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI; Murray TK; Green AR Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129 [TBL] [Abstract][Full Text] [Related]
3. The neurotoxic effects of p-chloroamphetamine in rat brain are blocked by prior depletion of serotonin. Berger UV; Grzanna R; Molliver ME Brain Res; 1992 Apr; 578(1-2):177-85. PubMed ID: 1511276 [TBL] [Abstract][Full Text] [Related]
4. Dextromethorphan antagonizes the acute depletion of brain serotonin by p-chloroamphetamine and H75/12 in rats. Henderson MG; Fuller RW Brain Res; 1992 Oct; 594(2):323-6. PubMed ID: 1280529 [TBL] [Abstract][Full Text] [Related]
5. Forebrain serotonin and avoidance learning: behavioural and biochemical studies on the acute effect of p-chloroamphetamine on one-way active avoidance learning in the male rat. Ogren SO Pharmacol Biochem Behav; 1982 Jun; 16(6):881-95. PubMed ID: 7111347 [TBL] [Abstract][Full Text] [Related]
6. Lack of neuroprotective effect of sigma receptor ligands in the neurotoxicity of p-chloroamphetamine in rat brain. Narita N; Hashimoto K; Iyo M; Minabe Y; Yamazaki K Eur J Pharmacol; 1995 Oct; 293(3):277-80. PubMed ID: 8666047 [TBL] [Abstract][Full Text] [Related]
7. The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine. Farfel GM; Vosmer GL; Seiden LS Brain Res; 1992 Nov; 595(1):121-7. PubMed ID: 1361410 [TBL] [Abstract][Full Text] [Related]
8. p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Sharp T; Zetterström T; Christmanson L; Ungerstedt U Neurosci Lett; 1986 Dec; 72(3):320-4. PubMed ID: 3822235 [TBL] [Abstract][Full Text] [Related]
9. Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. Farfel GM; Seiden LS J Pharmacol Exp Ther; 1995 Feb; 272(2):868-75. PubMed ID: 7853205 [TBL] [Abstract][Full Text] [Related]
10. Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta,beta-difluoro-p-chloroamphetamine in rats. Henderson MG; Perry KW; Fuller RW J Pharmacol Exp Ther; 1993 Oct; 267(1):417-24. PubMed ID: 8229770 [TBL] [Abstract][Full Text] [Related]
11. Depletion of serotonin using p-chlorophenylalanine (PCPA) and reserpine protects against the neurotoxic effects of p-chloroamphetamine (PCA) in the brain. Berger UV; Grzanna R; Molliver ME Exp Neurol; 1989 Feb; 103(2):111-5. PubMed ID: 2521470 [TBL] [Abstract][Full Text] [Related]
12. Endogenously produced 5,6-dihydroxytryptamine may mediate the neurotoxic effects of para-chloroamphetamine. Commins DL; Axt KJ; Vosmer G; Seiden LS Brain Res; 1987 Sep; 419(1-2):253-61. PubMed ID: 2445423 [TBL] [Abstract][Full Text] [Related]
13. Long-term reduction of brain serotonin by p-chloroamphetamine: effects of inducers and inhibitors of drug metabolism. Steranka LR; Sanders-Bush E J Pharmacol Exp Ther; 1978 Aug; 206(2):460-7. PubMed ID: 682126 [TBL] [Abstract][Full Text] [Related]
14. Tryptophan pretreatment augmentation of p-chloroamphetamine-induced serotonin and dopamine release and reduction of long-term neurotoxicity. Iyer RN; Sprouse JS; Aghajanian GK; Roth RH; Bradberry CW Biochem Pharmacol; 1994 Oct; 48(7):1501-8. PubMed ID: 7945451 [TBL] [Abstract][Full Text] [Related]
15. Evidence for selective serotonergic receptor involvement in p-chloroamphetamine-induced antinociception. Ogren SO; Berge OG Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):135-40. PubMed ID: 4010792 [TBL] [Abstract][Full Text] [Related]
16. Differential sensitivities to the lethal, but not the neurotoxic, effects of p-chloroamphetamine in inbred rat strains. Fernandez F; Aguerre S; Mormède P; Chaouloff F Neurosci Lett; 2001 Jan; 297(1):53-7. PubMed ID: 11114483 [TBL] [Abstract][Full Text] [Related]
17. Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. Mamounas LA; Mullen CA; O'Hearn E; Molliver ME J Comp Neurol; 1991 Dec; 314(3):558-86. PubMed ID: 1814975 [TBL] [Abstract][Full Text] [Related]
18. Unlike systemic administration of p-chloroamphetamine, direct intracerebral injection does not produce degeneration of 5-HT axons. Berger UV; Molliver ME; Grzanna R Exp Neurol; 1990 Sep; 109(3):257-68. PubMed ID: 2209770 [TBL] [Abstract][Full Text] [Related]
19. Mechanism by which uptake inhibitors antagonize p-chloroamphetamine-induced depletion of brain serotonin. Fuller RW Neurochem Res; 1980 Mar; 5(3):241-5. PubMed ID: 7374882 [TBL] [Abstract][Full Text] [Related]
20. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT. Misane I; Ogren SO Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]